RGNT

Regentis Biomaterials
RGNT

3 hedge funds and large institutions have $1.69M invested in Regentis Biomaterials in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.44M
2
+$1.6K

Top Sellers

1
-$127K
2
-$70.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$917K
RA
2
Rosalind Advisors
Ontario, Canada
$768K
UBS Group
3
UBS Group
Switzerland
$1.02K
WAM
4
Warberg Asset Management
Illinois
–
Citadel Advisors
5
Citadel Advisors
Florida
–